Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

Part of paid clinical trials in Bryant, Arkansas.

Sponsor
Bristol-Myers Squibb
Study ID
NCT07379827
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to describe real-world treatment patterns, effectiveness and adverse events of adults diagnosed with schizophrenia that have initiated xanomeline and trospium chloride (KarXT) treatment in the United States

Key Dates

Start date
Feb 26, 2026
Status verified
Jun 2026
Primary completion
Jun 20, 2028
Completion
Jun 20, 2028

Study Design

Enrollment
1,500 participants (estimated)

Arms

  • Arm: Group 1
    Participants diagnosed with schizophrenia receiving xanomeline and trospium chloride (KarXT)

Primary Outcome Measure

Treatment titration and switch regimens as described by the prescribing clinician [ Time Frame: Baseline and up to 20 weeks ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (52)

FacilityCityStateZIPSite coordinators
SanRo Clinical Research GroupBryantArkansas72022
Robert Wooten, Site 0009
Local Institution - 0003AnaheimCalifornia92805
Site 0003
Local Institution - 0047AnaheimCalifornia92801
Site 0047
Local Institution - 0039ChinoCalifornia91710
Site 0039
Local Institution - 0012La PalmaCalifornia90623
Site 0012
Local Institution - 0043OceansideCalifornia92056-4509
Site 0043
Local Institution - 0028StanfordCalifornia94304
Site 0028
Envision Trials LLCBonita SpringsFlorida34134
Daniel Mandri, Site 0005
305-819-2909
Galiz ResearchHialeahFlorida33016-1814
Jose Gamez, Site 0019
305-805-0921
Local Institution - 0030HomesteadFlorida33030
Site 0030
New Access Research & Medical Services Inc - KendallKendallFlorida33186
Ana Maria Tous, Site 0029
Banyan Behavioal Care Program - CSUMiamiFlorida33134
Moraima Trujillo, Site 0011
305-246-0001
BioResearch Partner - MiamiMiamiFlorida33175
Fenton Lebon, Site 0006
Local Institution - 0007MiamiFlorida33155
Site 0007
Local Institution - 0032MiamiFlorida33015
Site 0032
Medical Research of Central FloridaOrange CityFlorida32763
Adly Thebaud, Site 0023
386-775-7627
Local Institution - 0040OrlandoFlorida32803
Site 0040
Local Institution - 0025AtlantaGeorgia30303
Site 0025
Local Institution - 0049AustellGeorgia30106
Site 0049
Local Institution - 0044MariettaGeorgia30060
Site 0044
Local Institution - 0046Crystal LakeIllinois60523
Site 0046
Local Institution - 0048WarrenvilleIllinois60555
Site 0048
Local Institution - 0014Bloomfield TownshipMichigan48302-1909
Site 0014
Local Institution - 0036DetroitMichigan48203
Site 0036
Local Institution - 0034Apple ValleyMinnesota55124
Site 0034
Local Institution - 0041LincolnNebraska68526-9474
Site 0041
Local Institution - 0037BuffaloNew York14215
Site 0037
Local Institution - 0004MonseyNew York10952
Site 0004
Local Institution - 0038RochesterNew York14623
Site 0038
Local Institution - 0020White PlainsNew York10601
Site 0020
Local Institution - 0042CaryNorth Carolina27513
Site 0042
PPD Virtual - PPD - USWilmingtonNorth Carolina28401-3331
Ghazaleh Bahrami, Site 0001
866-609-3139
Local Institution - 0031MasonOhio45040-7846
Site 0031
The Rivus Wellness & Research InstituteOklahoma CityOklahoma73112-8729
Marvin Peyton, Site 0027
405-317-5783
Local Institution - 0052TulsaOklahoma74135
Site 0052
Perelman School of Medicine at the University of PennsylvaniaPhiladelphiaPennsylvania19104-4238
Raquel Gur, Site 0015
215-662-2915
Local Institution - 0051CordovaTennessee38018
Site 0051
Psychiatric Consultants, PcFranklinTennessee37607
James Hart, Site 0002
615-807-4025
Local Institution - 0016AustinTexas78754
Site 0016
Local Institution - 0050DallasTexas75390
Site 0050
Local Institution - 0021Fort WorthTexas76132
Site 0021
Local Institution - 0010HoustonTexas77054
Site 0010
Local Institution - 0022HoustonTexas77054-2852
Site 0022
Local Institution - 0026HoustonTexas77008-1758
Site 0026
Local Institution - 0033HoustonTexas77007-9015
Site 0033
Pioneer Research Solutions, Inc.HoustonTexas77099
Ateka Zaki, Site 0024
Local Institution - 0017IrvingTexas75062-2757
Site 0017
Local Institution - 0013McKinneyTexas75092
Site 0013
Perceptive Pharma ResearchRichmondTexas77407-3498
Adeeb Masood, Site 0008
Local Institution - 0035San AntonioTexas78240
Site 0035
Local Institution - 0018StaffordTexas77477-3954
Site 0018
Local Institution - 0045PetersburgVirginia23805
Site 0045

Find similar trials in Bryant, AR

By condition
Schizophrenia
By specialty
PsychiatryMental healthBehavioral health
By research site
SanRo Clinical Research Group· Bryant, ARLocal Institution - 0003· Anaheim, CALocal Institution - 0047· Anaheim, CALocal Institution - 0039· Chino, CALocal Institution - 0012· La Palma, CALocal Institution - 0043· Oceanside, CA

Related Studies